REDUCEDT+2
PTC Therapeutics Inc · NASDAQ
−2,447 sh · $155.1K
Filed 9 Oct 2026SEC Form 4view source
- REDUCEDT+2
PTC Therapeutics Inc · NASDAQ
−53 sh · $3.4K
Filed 9 Oct 2026SEC Form 4view source - ACQUIREDT+30
Hamilton Lane Inc · NASDAQ
+977 sh
Filed 18 Sept 2026SEC Form 4view source - REDUCEDT+30
PTC Therapeutics Inc · NASDAQ
−9,624 sh · $652.8K
Filed 18 Sept 2026SEC Form 4view source - REDUCEDT+30
PTC Therapeutics Inc · NASDAQ
−2,994 sh · $199.3K
Filed 18 Sept 2026SEC Form 4view source - REDUCEDT+30
PTC Therapeutics Inc · NASDAQ
−376 sh · $25.7K
Filed 18 Sept 2026SEC Form 4view source - REDUCEDT+30
PTC Therapeutics Inc · NASDAQ
−7,006 sh · $471.9K
Filed 18 Sept 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−9,428 sh · $639.1K
Filed 11 Sept 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−572 sh · $39.3K
Filed 11 Sept 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−10,000 sh · $673.4K
Filed 11 Sept 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−11,890 sh · $850.7K
Filed 28 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−6,874 sh · $500.0K
Filed 28 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−610 sh · $44.1K
Filed 28 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−5,626 sh · $411.7K
Filed 28 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−691 sh · $50.4K
Filed 21 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−2,390 sh · $171.8K
Filed 21 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−5,335 sh · $388.7K
Filed 21 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−7,165 sh · $527.8K
Filed 21 Aug 2026SEC Form 4view source - REDUCEDStale
PTC Therapeutics Inc · NASDAQ
−9,419 sh · $666.7K
Filed 21 Aug 2026SEC Form 4view source